These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 16548716)

  • 1. Role of the HIV/AIDS case manager: analysis of a case management adherence training and coordination program in North Carolina.
    Shelton RC; Golin CE; Smith SR; Eng E; Kaplan A
    AIDS Patient Care STDS; 2006 Mar; 20(3):193-204. PubMed ID: 16548716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medication adherence practices of HIV/AIDS case managers: a statewide survey in North Carolina.
    Reif S; Smith SR; Golin CE
    AIDS Patient Care STDS; 2003 Sep; 17(9):471-81. PubMed ID: 14588085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a case management program for HIV clients in Rwanda.
    Thurman TR; Haas LJ; Dushimimana A; Lavin B; Mock N
    AIDS Care; 2010 Jun; 22(6):759-65. PubMed ID: 20461574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Barriers to accessing HIV/AIDS care in North Carolina: rural and urban differences.
    Reif S; Golin CE; Smith SR
    AIDS Care; 2005 Jul; 17(5):558-65. PubMed ID: 16036242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barriers to adherence to highly active antiretroviral therapy as expressed by people living with HIV/AIDS.
    Proctor VE; Tesfa A; Tompkins DC
    AIDS Patient Care STDS; 1999 Sep; 13(9):535-44. PubMed ID: 10813033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vets, denialists and rememberers: social typologies of patient adherence and non-adherence to HAART from the perspective of HIV care providers.
    Orchard T; Salters K; Palmer A; Michelow W; Lepik KJ; Hogg R
    AIDS Care; 2015; 27(6):758-61. PubMed ID: 25635938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of HIV/AIDS case management in New York.
    Lehrman SE; Gentry D; Yurchak BB; Freedman J
    AIDS Care; 2001 Aug; 13(4):481-92. PubMed ID: 11454269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
    Cruess DG; Minor S; Antoni MH; Millon T
    J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Client Adherence Profiling-Intervention Tailoring (CAP-IT) intervention for enhancing adherence to HIV/AIDS medications: a pilot study.
    Holzemer WL; Henry SB; Portillo CJ; Miramontes H
    J Assoc Nurses AIDS Care; 2000; 11(1):36-44. PubMed ID: 10670005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to antiretroviral adherence among HIV-infected adults.
    Murphy DA; Roberts KJ; Martin DJ; Marelich W; Hoffman D
    AIDS Patient Care STDS; 2000 Jan; 14(1):47-58. PubMed ID: 12240882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adherence to HAART: perspectives from clients in treatment support programs.
    Weiss L; French T; Waters M; Netherland J; Agins B; Finkelstein R
    Psychol Health Med; 2006 May; 11(2):155-70. PubMed ID: 17129905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV medication adherence programs: the importance of social support.
    Bontempi JM; Burleson L; Lopez MH
    J Community Health Nurs; 2004; 21(2):111-22. PubMed ID: 15123440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outpatient pharmacy care and HIV viral load response among patients on HAART.
    Castillo E; Palepu A; Beardsell A; Akagi L; Yip B; Montaner JS; Hogg RS
    AIDS Care; 2004 May; 16(4):446-57. PubMed ID: 15203413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
    Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
    Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication-Taking Practices of Patients on Antiretroviral HIV Therapy: Control, Power, and Intentionality.
    Muessig KE; Panter AT; Mouw MS; Amola K; Stein KE; Murphy JS; Maiese EM; Wohl DA
    AIDS Patient Care STDS; 2015 Nov; 29(11):606-16. PubMed ID: 26505969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater adherence to highly active antiretroviral therapy (HAART) between pregnant versus non-pregnant women living with HIV.
    Zorrilla CD; Santiago LE; Knubson D; Liberatore K; Estronza G; Colón O; Acevedo M
    Cell Mol Biol (Noisy-le-grand); 2003 Dec; 49(8):1187-92. PubMed ID: 14983985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intention to adhere to HIV treatment: a patient-centred predictor of antiretroviral adherence.
    Nelsen A; Gupta S; Trautner BW; Petersen NJ; Garza A; Giordano TP; Naik AD; Rodriguez-Barradas MC
    HIV Med; 2013 Sep; 14(8):472-80. PubMed ID: 23551395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
    Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
    Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secret pills: HIV-positive patients' experiences taking antiretroviral therapy in North Carolina.
    Golin C; Isasi F; Bontempi JB; Eng E
    AIDS Educ Prev; 2002 Aug; 14(4):318-29. PubMed ID: 12212718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.